Trials / Completed
CompletedNCT04829045
Effects of Acupuncture as Adjunctive Therapy in Patients With Type 2 Diabetes Mellitus
The Effect of Acupuncture as Adjunctive Therapy on Homeostasis Model Assessment-insulin Resistance and Health Related Quality of Life in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Universiti Putra Malaysia · Academic / Other
- Sex
- All
- Age
- 30 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the effect of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR) and health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus.
Detailed description
This is a randomised, double-blind, placebo controlled and parallel design trial. Participants will be randomized to either acupuncture (n=30) or placebo (n=30) using a 1:1 ratio. The permuted blocks with a block size of 2 will be used. Both groups will continue with their routine diabetes care. Primary outcome of HOMA-IR will be measured at the time of recruitment (baseline) and after completion of 10 sessions (week 7) of the treatment. Secondary outcome of HRQOL will be measured at the time of recruitment (baseline), after completion of 5 sessions (week 3/4) and 10 sessions (week 7) of the treatment while outcomes of body mass index and waist circumference are measured at the time of recruitment (baseline) and after completion of 10 sessions (week 7) of the treatment. Any adverse event will be recorded at every visit. The sequence generation and allocation will remain concealed from the patient and practitioner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SEIRIN PYONEX Acupuncture Needles | 10 press needles (PYONEX ø0.20×1.5mm made by Seirin Corporation) will be placed on abdomen area; 10 sessions over 6 weeks. |
| OTHER | PYONEX Placebo | Subjects are given placebo on abdomen area; 10 sessions over 6 weeks. |
Timeline
- Start date
- 2021-05-27
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-04-02
- Last updated
- 2023-10-12
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT04829045. Inclusion in this directory is not an endorsement.